BELANTAMAB MAFODOTIN for Plasma cell myeloma refractory: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 113 adverse event reports in the FDA FAERS database where BELANTAMAB MAFODOTIN was used for Plasma cell myeloma refractory.
Most Reported Side Effects for BELANTAMAB MAFODOTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Keratopathy | 788 | 34.4% | 181 | 79 |
| Visual acuity reduced | 708 | 30.9% | 152 | 65 |
| Death | 499 | 21.8% | 499 | 50 |
| Plasma cell myeloma | 380 | 16.6% | 191 | 61 |
| Dry eye | 359 | 15.7% | 43 | 31 |
| Night blindness | 317 | 13.8% | 24 | 18 |
| Photophobia | 183 | 8.0% | 12 | 12 |
| Foreign body sensation in eyes | 151 | 6.6% | 9 | 10 |
| Vision blurred | 134 | 5.8% | 20 | 17 |
| Ocular toxicity | 94 | 4.1% | 18 | 5 |
| Punctate keratitis | 91 | 4.0% | 16 | 10 |
| Thrombocytopenia | 90 | 3.9% | 39 | 35 |
| Visual impairment | 86 | 3.8% | 9 | 8 |
| Eye disorder | 75 | 3.3% | 11 | 9 |
| Corneal epithelial microcysts | 74 | 3.2% | 9 | 7 |
Other Indications for BELANTAMAB MAFODOTIN
Plasma cell myeloma (1,382)
Product used for unknown indication (786)
Bone lesion (9)
Disease progression (6)
Amyloidosis (5)
Other Drugs Used for Plasma cell myeloma refractory
DEXAMETHASONE (2,276)
POMALIDOMIDE (1,562)
LENALIDOMIDE (1,220)
CARFILZOMIB (1,208)
BORTEZOMIB (848)
DARATUMUMAB (789)
ISATUXIMAB (778)
CYCLOPHOSPHAMIDE (518)
IXAZOMIB (356)
DOXORUBICIN (314)